Head of Investor Relations
Denali Therapeutics Inc. (DNLI)Equibles does not estimate personal net worth.
Get an email with a short summary when Denali Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get DNLI alertsLaura Hansen is recorded as Head of Investor Relations at Denali Therapeutics Inc. (DNLI). Laura Hansen has spoken on 3 earnings calls across 1 company, most recently for Denali Therapeutics Inc. on November 3, 2026. Denali Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Denali Therapeutics Inc. includes Ryan J. Watts (CEO and Board Member), Alexander Schuth (CFO), Steve E. Krognes (CFO and Board Member) and 7 others.
“Good afternoon, everyone, and thank you for joining us to discuss Denali Therapeutics' third quarter 2026 financial results and business highlights. Earlier today, we issued our press release and filed a quarterly report.”
“Good afternoon, everyone, and thank you for joining us today to discuss Denali Therapeutics second quarter, 2026, financial results and business highlights. Earlier today, we issued our earnings press release and filed our quarterly report.”
“It's a pleasure to have the Denali team here with us. We have Ryan Watts, CEO, and Alex Schuth, CFO. To start here, the recent approval of Avalaya and Hunter syndrome serves as Denali's first commercial launch and the first from the transport vehicle platform.”
Biotechnology · Healthcare
Head of Investor Relations
